Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidex for Acute Otitis Externa
NCT00750633Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jun 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of moxifloxacin + dexamethasone in acute otitis externa (AOE) (3 arms), sponsored by Alcon Inc. Primary endpoint: Clinical Cure at Day 3. Started Jun 2008; status: completed.
02
Drugs
moxifloxacin + dexamethasone
03
Conditions
acute otitis externa (AOE)
Beyond the preview
Go deeper on NCT00750633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00750633.